MARKET

WVE

WVE

Wave Life Scienc
NASDAQ
6.43
-0.17
-2.58%
Opening 09:50 05/13 EDT
OPEN
6.61
PREV CLOSE
6.60
HIGH
6.65
LOW
6.36
VOLUME
62.97K
TURNOVER
--
52 WEEK HIGH
16.74
52 WEEK LOW
4.250
MARKET CAP
991.08M
P/E (TTM)
-7.7685
1D
5D
1M
3M
1Y
5Y
1D
Wave Life Sciences: Strategic Advancements and Promising Developments Justify Buy Rating
TipRanks · 1d ago
Weekly Report: what happened at WVE last week (0505-0509)?
Weekly Report · 1d ago
Innovative Therapeutics and Promising Clinical Data Drive Buy Rating for Wave Life Sciences
TipRanks · 4d ago
Truist Financial Reaffirms Their Buy Rating on Wave Life Sciences (WVE)
TipRanks · 4d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alpha Teknova (TKNO), Definitive Healthcare Corp (DH) and Wave Life Sciences (WVE)
TipRanks · 4d ago
RBC Capital Keeps Their Hold Rating on Wave Life Sciences (WVE)
TipRanks · 4d ago
Wave Life Sciences Reports Q1 2025 Financials and Progress
TipRanks · 4d ago
BUZZ-U.S. STOCKS ON THE MOVE-MercadoLibre, Crocs, Paycom Software
Reuters · 4d ago
More
About WVE
More
Wave Life Sciences Ltd. is a biotechnology company. The Company is focused on unlocking the potential of RNA medicines (oligonucleotides), or those targeting ribonucleic acid (RNA), to transform human health. Its RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing and RNA interference (RNAi), providing Company with capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency and Huntington’s disease, as well as a preclinical program in obesity. These programs include WVE-N531, WVE-006 and WVE-003. It is also building a pipeline of novel A-to-I RNA editing oligonucleotides (AIMers).
Recently
Symbol
Price
%Change

Webull offers Wave Life Sciences Ltd stock information, including NASDAQ: WVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, WVE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading WVE stock methods without spending real money on the virtual paper trading platform.